Sanj K Patel Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Sanj K Patel is CHAIRMAN & CEO of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 79,551 shares of KNSA, which is worth approximately $1.6 Million. The most recent transaction as insider was on Nov 06, 2024, when has been sold 89,561 shares (Class A Ordinary Share) at a price of $23.0 per share, resulting in proceeds of $2,059,903. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.6K

0% 3M change

51.48% 12M change

Total Value Held $1.6 Million

Sanj K Patel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 06 2024	SELL Open market or private sale	$2,059,903 $23.0 p/Share	89,561 Reduced 52.96%	79,551 Class A Ordinary Share
Nov 06 2024	BUY Exercise of conversion of derivative security	$142,401 $1.59 p/Share	89,561 Added 34.62%	169,112 Class A Ordinary Share
Sep 02 2024	SELL Payment of exercise price or tax liability	$84,952 $26.74 p/Share	3,177 Reduced 3.84%	79,551 Class A Ordinary Share
Sep 02 2024	BUY Exercise of conversion of derivative security	-	6,569 Added 7.36%	82,728 Class A Ordinary Share
Sep 01 2024	SELL Payment of exercise price or tax liability	$213,037 $26.74 p/Share	7,967 Reduced 9.47%	76,159 Class A Ordinary Share
Sep 01 2024	BUY Exercise of conversion of derivative security	-	16,474 Added 16.38%	84,126 Class A Ordinary Share
Jul 23 2024	SELL Open market or private sale	$3,416,712 $25.1 p/Share	136,124 Reduced 68.36%	63,012 Class A Ordinary Share
Jul 23 2024	BUY Exercise of conversion of derivative security	$216,437 $1.59 p/Share	136,124 Added 40.6%	199,136 Class A Ordinary Share
Apr 08 2024	SELL Payment of exercise price or tax liability	$72,942 $17.9 p/Share	4,075 Reduced 6.07%	63,012 Class A Common Share
Apr 08 2024	BUY Exercise of conversion of derivative security	-	9,992 Added 12.96%	67,087 Class A Common Share
Apr 01 2024	SELL Payment of exercise price or tax liability	$37,489 $19.7 p/Share	1,903 Reduced 3.23%	57,095 Class A Common Share
Apr 01 2024	BUY Exercise of conversion of derivative security	-	6,482 Added 9.9%	58,998 Class A Common Share
Sep 02 2023	SELL Payment of exercise price or tax liability	$38,841 $17.76 p/Share	2,187 Reduced 4.0%	52,516 Class A Common Share
Sep 02 2023	BUY Exercise of conversion of derivative security	-	6,569 Added 10.72%	54,703 Class A Common Share
Sep 01 2023	SELL Payment of exercise price or tax liability	$78,712 $17.76 p/Share	4,432 Reduced 8.43%	48,134 Class A Common Share
Sep 01 2023	BUY Exercise of conversion of derivative security	-	9,992 Added 15.97%	52,566 Class A Common Share
Apr 10 2023	SELL Payment of exercise price or tax liability	$31,412 $10.71 p/Share	2,933 Reduced 6.45%	42,574 Class A Common Share
Apr 10 2023	BUY Exercise of conversion of derivative security	-	9,992 Added 18.0%	45,507 Class A Common Share
Mar 20 2023	SELL Payment of exercise price or tax liability	$39,175 $11.12 p/Share	3,523 Reduced 9.02%	35,515 Class A Common Share
Mar 20 2023	BUY Exercise of conversion of derivative security	-	12,002 Added 23.51%	39,038 Class A Common Share
Mar 16 2023	SELL Payment of exercise price or tax liability	$22,106 $11.46 p/Share	1,929 Reduced 6.66%	27,036 Class A Common Share
Mar 16 2023	BUY Exercise of conversion of derivative security	-	6,569 Added 18.49%	28,965 Class A Common Share
Sep 02 2022	SELL Payment of exercise price or tax liability	$22,068 $11.44 p/Share	1,929 Reduced 7.93%	22,396 Class A Common Share
Sep 02 2022	BUY Exercise of conversion of derivative security	-	6,569 Added 21.26%	24,325 Class A Common Share
Mar 21 2022	SELL Payment of exercise price or tax liability	$59,797 $10.98 p/Share	5,446 Reduced 23.47%	17,756 Class A Common Share

SKP

Sanj K Patel

CHAIRMAN & CEO

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account